Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark Schuette"'
Autor:
Thomas Clarke, Pan Du, Satyendra Kumar, Shinji L. Okitsu, Mark Schuette, Qi An, Jinyang Zhang, Evgeni Tzvetkov, Mark A. Jensen, Timothy B. Niewold, Elise M. N. Ferre, Julie Nardone, Michail S. Lionakis, Jaromir Vlach, Julie DeMartino, Andrew T. Bender
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Autoimmune diseases vary in the magnitude and diversity of autoantibody profiles, and these differences may be a consequence of different types of breaks in tolerance. Here, we compared the disparate autoimmune diseases autoimmune polyendocrinopathy
Externí odkaz:
https://doaj.org/article/e823a778e94642ba916ed495ae37f622
Autor:
Valerie, Schmieder, Juergen, Fieder, Raphael, Drerup, Erik Arango, Gutierrez, Carina, Guelch, Jessica, Stolzenberger, Mihaela, Stumbaum, Volker Steffen, Mueller, Fabian, Higel, Martin, Bergbauer, Kim, Bornhoefft, Manuel, Wittner, Petra, Gronemeyer, Christian, Braig, Michaela, Huber, Anita, Reisenauer-Schaupp, Markus Michael, Mueller, Mark, Schuette, Sebastian, Puengel, Benjamin, Lindner, Moritz, Schmidt, Patrick, Schulz, Simon, Fischer
Publikováno v:
Journal of Biotechnology. 349:53-64
In recent years, acceleration of development timelines has become a major focus within the biopharmaceutical industry to bring innovative therapies faster to patients. However, in order to address a high unmet medical need even faster further acceler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1165b316d49d192541a4904d47249f27
https://doi.org/10.1016/j.jbiotec.2022.03.010
https://doi.org/10.1016/j.jbiotec.2022.03.010
Autor:
Mark Schuette, John S. Wesolowski, Harald Kolmar, Vanita D. Sood, Christine Knuehl, Bjoern Hock, Annika Messemer, Lars Toleikis, Simon Krah, Achim Doerner, Nicolas Rasche, Laura Rhiel, Carolin Sellmann, Stefan Becker
Publikováno v:
The Journal of biological chemistry. 291(48)
Bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs) have already demonstrated benefits for the treatment of cancer in several clinical studies, showing improved drug selectivity and efficacy. In particular, simultaneous targeting of pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66e9929c5771a3e25e4bf897d6b283da
https://pubmed.ncbi.nlm.nih.gov/27694443
https://pubmed.ncbi.nlm.nih.gov/27694443